Search results
Results from the WOW.Com Content Network
Azithromycin, sold under the brand names Zithromax (in oral form) and Azasite (as an eye drop), is an antibiotic medication used for the treatment of several bacterial infections. [10] This includes middle ear infections , strep throat , pneumonia , traveler's diarrhea , and certain other intestinal infections . [ 10 ]
Printable version; In other projects Wikidata item; Appearance. move to sidebar hide. This is a list of drugs and ... Zithromax Barbiturates [4] Carbamazepine [5]
The Prescribing Information follows one of two formats: "physician labeling rule" format or "old" (non-PLR) format. For "old" format labeling a "product title" may be listed first and may include the proprietary name (if any), the nonproprietary name, dosage form(s), and other information about the product. The other sections are as follows:
From or to a drug trade name: This is a redirect from (or to) the trade name of a drug to (or from) the international nonproprietary name (INN). When appropriate, protection levels are automatically sensed, described and categorized.
The drug safety communication also announced the required labeling updates to reflect this new safety information. [85] The FDA put out another label change in July 2017, strengthening the warnings about potentially disabling adverse effects and limiting use of these drugs to second-line treatments for acute sinusitis, acute bronchitis, and ...
Figure 2. Box-plot with whiskers from minimum to maximum Figure 3. Same box-plot with whiskers drawn within the 1.5 IQR value. A boxplot is a standardized way of displaying the dataset based on the five-number summary: the minimum, the maximum, the sample median, and the first and third quartiles.
Modified-release dosage is a mechanism that (in contrast to immediate-release dosage) delivers a drug with a delay after its administration (delayed-release dosage) or for a prolonged period of time (extended-release [ER, XR, XL] dosage) or to a specific target in the body (targeted-release dosage).
A noted drug interaction involves erythromycin and simvastatin, resulting in increased simvastatin levels and the potential for rhabdomyolysis. Another group of CYP3A4 substrates are drugs used for migraine such as ergotamine and dihydroergotamine ; their adverse effects may be more pronounced if erythromycin is associated.